S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CDXC ChromaDex Corporation

5.42

-0.02 (-0.37%)

Last Updated: 08:32:29

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more ChromaDex Charts.

ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more ChromaDex Charts.

ChromaDex Corporation News

Form 8-K - Current report
Monday 16 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 13 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 13 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 4 December 2024 (3 weeks ago) • Edgar (US Regulatory)

ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category
Tuesday 3 December 2024 (3 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 21 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 21 November 2024 (1 month ago) • Edgar (US Regulatory)

ChromaDex’s Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement
Thursday 14 November 2024 (1 month ago) • Business Wire

Form 3 - Initial statement of beneficial ownership of securities
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide
Thursday 7 November 2024 (2 months ago) • Business Wire

ChromaDex Corporation Reports Third Quarter 2024 Financial Results
Thursday 31 October 2024 (2 months ago) • Business Wire

More ChromaDex Corporation News Articles

Elite Pharmaceuticals (QB)

North Bay Resources (PK)

Anavex Life Sciences

Fannie Mae (QB)

Code Green Apparel (PK)

Digital Brand Media and ... (PK)

Northwest Biotherapeutics (QB)

Lightwave Logic

Tonix Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions